The proliferative response of human or rat T lymphocytes to phytohemagglutinin (PHA) or concanavalin A (ConA) was measured after acute (30 min) or chronic (8 days) treatment with the opiate receptor antagonists naloxone or naltrexone. Both in the rat and in the human, proliferation was significantly enhanced by acute treatment with the opiate receptor antagonists. In contrast, after chronic treatment proliferation always decreased. The sudden removal of an opioid inhibitory tone might be the basis for the increased proliferative responses observed after acute treatment. The decrease after chronic treatment could be ascribed to the amplification of the inhibitory effect of endogenous opioids due to the up-regulation of opiate receptors that follows chronic antagonist administration. Receptor binding studies of β-endorphin receptors on splenocytes of chronically naloxone treated rats confirmed this hypothesis: a higher number of β-endorphin receptors were expressed on splenocytes of naloxone-treated rats compared to controls (Bmax = 9.8 × 10-12 vs. 1.16 × 10-12, respectively).

Evidence for an opioid inhibitory effect on T cell proliferation / B. Manfredi, P. Sacerdote, M. Bianchi, L. Locatelli, J. Vejic Radulovic, A.E. Panerai. - In: JOURNAL OF NEUROIMMUNOLOGY. - ISSN 0165-5728. - 44:1(1993), pp. 43-48.

Evidence for an opioid inhibitory effect on T cell proliferation

B. Manfredi;P. Sacerdote;M. Bianchi;A.E. Panerai
1993

Abstract

The proliferative response of human or rat T lymphocytes to phytohemagglutinin (PHA) or concanavalin A (ConA) was measured after acute (30 min) or chronic (8 days) treatment with the opiate receptor antagonists naloxone or naltrexone. Both in the rat and in the human, proliferation was significantly enhanced by acute treatment with the opiate receptor antagonists. In contrast, after chronic treatment proliferation always decreased. The sudden removal of an opioid inhibitory tone might be the basis for the increased proliferative responses observed after acute treatment. The decrease after chronic treatment could be ascribed to the amplification of the inhibitory effect of endogenous opioids due to the up-regulation of opiate receptors that follows chronic antagonist administration. Receptor binding studies of β-endorphin receptors on splenocytes of chronically naloxone treated rats confirmed this hypothesis: a higher number of β-endorphin receptors were expressed on splenocytes of naloxone-treated rats compared to controls (Bmax = 9.8 × 10-12 vs. 1.16 × 10-12, respectively).
Concanavalin A; Mitogen; Opioid; Phytohemagglutinin; Proliferation
Settore BIO/14 - Farmacologia
1993
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/181882
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 83
  • ???jsp.display-item.citation.isi??? 81
social impact